Introduction: Cross-sectional findings using the tau tracer [ 18 F]THK5317 (THK5317) have shown that [
Introduction
In addition to amyloid-b (Ab) and tau pathology, Alzheimer's disease (AD) is characterized by decreased brain perfusion [1, 2] and glucose metabolism [3, 4] . Cross-sectional comparative studies have indeed shown regional perfusion and metabolism to be tightly coupled in neurodegenerative disorders, including AD [5, 6] , and in controls, under both active and resting physiological conditions [7] . As such, [ 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54 
